BRIC – University of Copenhagen

Biotech Research & Innovation Centre

Schizophrenia

Huge unveiling of schizophrenia brain cells show new treatment targets

Clinical trial illustration

Translational AML trial improves clinical outcome and identifies novel drugs for future treatment

Spatial transcriptomics figure

CellX Infrastructure Network strengthens single cell omics in DK and at BRIC

BioPhenyx founders

New gene technology can reveal how well medicine works

The immune system can help us diagnose cancer

The immune system can help us diagnose cancer

News

Huge unveiling of schizophrenia brain cells show new treatment targets

For the first time, researchers show how schizophrenia affects both the single cell and regional cell networks in the brain. The study may provide new options for treating the disease.

Translational AML trial improves clinical outcome and identifies novel drugs for future treatment

The LD-VenEx trial exemplifies the vast potential of clinical trials integrating translational research programs, says research group leader Kim Theilgaard-Mönch. In a large investigator-initiated trial, clinicians form…

CellX Infrastructure Network strengthens single cell omics in Denmark and at BRIC

The Danish Ministry of Higher Education and Science has granted now DKK 51 million to the ‘CellX’ project, which aims to provide researchers across Denmark with better access to the analysis of cells and tissues at…

Upcoming events at BRIC

9 Dec. 2022, 9:30-12:30

PhD defence: Lluis Riera Ponsati

Title: Linking Interferon Signaling and Mitochondrial Homeostasis in Parkinsonian disorders

19 Dec. 2022, 13:00-16:00

PhD defence: Sophia Manon Charlotte Engelhard

Title: Functional Characterisation of Endomucin in Haematopoietic Stem Cells

Show all events

Tweets by UCPH_BRIC

Students and PostDocs

EU-life network

Follow us on LinkedIn